Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Nitric Oxide Donor NOC-18-Induced Changes of Mitochondrial Phosphoproteome in Rat Cardiac Ischemia Model.

Umbrasas D, Jokubka R, Kaupinis A, Valius M, Arandarčikaitė O, Borutaitė V.

Medicina (Kaunas). 2019 Sep 24;55(10). pii: E631. doi: 10.3390/medicina55100631.

2.

Geobacillin 26 - high molecular weight bacteriocin from a thermophilic bacterium.

Vaičikauskaitė M, Ger M, Valius M, Maneikis A, Lastauskienė E, Kalėdienė L, Kaunietis A.

Int J Biol Macromol. 2019 Sep 6;141:333-344. doi: 10.1016/j.ijbiomac.2019.09.047. [Epub ahead of print]

PMID:
31499103
3.

Oxidative phosphorylation inhibition induces anticancerous changes in therapy-resistant-acute myeloid leukemia patient cells.

Vitkevičienė A, Janulis V, Žučenka A, Borutinskaitė V, Kaupinis A, Valius M, Griškevičius L, Navakauskienė R.

Mol Carcinog. 2019 Nov;58(11):2008-2016. doi: 10.1002/mc.23092. Epub 2019 Aug 6.

PMID:
31385375
4.

Proteomic Analysis of Breast Cancer Resistance to the Anticancer Drug RH1 Reveals the Importance of Cancer Stem Cells.

Kuciauskas D, Dreize N, Ger M, Kaupinis A, Zemaitis K, Stankevicius V, Suziedelis K, Cicenas J, Graves LM, Valius M.

Cancers (Basel). 2019 Jul 11;11(7). pii: E972. doi: 10.3390/cancers11070972.

5.

The post-abscission midbody is an intracellular signaling organelle that regulates cell proliferation.

Peterman E, Gibieža P, Schafer J, Skeberdis VA, Kaupinis A, Valius M, Heiligenstein X, Hurbain I, Raposo G, Prekeris R.

Nat Commun. 2019 Jul 18;10(1):3181. doi: 10.1038/s41467-019-10871-0.

6.

The Robust Self-Assembling Tubular Nanostructures Formed by gp053 from Phage vB_EcoM_FV3.

Šimoliūnas E, Truncaitė L, Rutkienė R, Povilonienė S, Goda K, Kaupinis A, Valius M, Meškys R.

Viruses. 2019 Jan 11;11(1). pii: E50. doi: 10.3390/v11010050.

7.

Pantoea Bacteriophage vB_PagS_Vid5: A Low-Temperature Siphovirus That Harbors a Cluster of Genes Involved in the Biosynthesis of Archaeosine.

Šimoliūnas E, Šimoliūnienė M, Kaliniene L, Zajančkauskaitė A, Skapas M, Meškys R, Kaupinis A, Valius M, Truncaitė L.

Viruses. 2018 Oct 25;10(11). pii: E583. doi: 10.3390/v10110583.

8.

Proteomic Identification of FLT3 and PCBP3 as Potential Prognostic Biomarkers for Pancreatic Cancer.

Ger M, Kaupinis A, Petrulionis M, Kurlinkus B, Cicenas J, Sileikis A, Valius M, Strupas K.

Anticancer Res. 2018 Oct;38(10):5759-5765. doi: 10.21873/anticanres.12914.

PMID:
30275197
9.

Mycobacteria produce proteins involved in biofilm formation and growth-affecting processes.

Korabliovienė J, Mauricas M, Ambrozevičienė Č, Valius M, Kaupinis A, Čaplinskas S, Korabliov P.

Acta Microbiol Immunol Hung. 2018 Aug 1;65(3):405-418. doi: 10.1556/030.65.2018.033. Epub 2018 Jul 19.

PMID:
30024267
10.

Molecular modeling and structure-based drug discovery approach reveals protein kinases as off-targets for novel anticancer drug RH1.

Gupta PP, Bastikar VA, Kuciauskas D, Kothari SL, Cicenas J, Valius M.

Med Oncol. 2017 Sep 6;34(10):176. doi: 10.1007/s12032-017-1011-5.

PMID:
28879492
11.

Construction, Purification, and Characterization of a Homodimeric Granulocyte Colony-Stimulating Factor.

Mickiene G, Dalgediene I, Dapkunas Z, Zvirblis G, Pesliakas H, Kaupinis A, Valius M, Mistiniene E, Pleckaityte M.

Mol Biotechnol. 2017 Oct;59(9-10):374-384. doi: 10.1007/s12033-017-0026-7.

PMID:
28721592
12.

Molecular Analysis of Arthrobacter Myovirus vB_ArtM-ArV1: We Blame It on the Tail.

Kaliniene L, Šimoliūnas E, Truncaitė L, Zajančkauskaitė A, Nainys J, Kaupinis A, Valius M, Meškys R.

J Virol. 2017 Mar 29;91(8). pii: e00023-17. doi: 10.1128/JVI.00023-17. Print 2017 Apr 15.

13.

KRAS, NRAS and BRAF mutations in colorectal cancer and melanoma.

Cicenas J, Tamosaitis L, Kvederaviciute K, Tarvydas R, Staniute G, Kalyan K, Meskinyte-Kausiliene E, Stankevicius V, Valius M.

Med Oncol. 2017 Feb;34(2):26. doi: 10.1007/s12032-016-0879-9. Epub 2017 Jan 10. Review.

PMID:
28074351
14.

Tailored Dual PEGylation of Inorganic Porous Nanocarriers for Extremely Long Blood Circulation in Vivo.

Nissinen T, Näkki S, Laakso H, Kučiauskas D, Kaupinis A, Kettunen MI, Liimatainen T, Hyvönen M, Valius M, Gröhn O, Lehto VP.

ACS Appl Mater Interfaces. 2016 Dec 7;8(48):32723-32731. Epub 2016 Nov 23.

PMID:
27934159
15.

Extracellular Matrix-dependent Pathways in Colorectal Cancer Cell Lines Reveal Potential Targets for Anticancer Therapies.

Stankevicius V, Vasauskas G, Noreikiene R, Kuodyte K, Valius M, Suziedelis K.

Anticancer Res. 2016 Sep;36(9):4559-67.

PMID:
27630296
16.

Incomplete LPS Core-Specific Felix01-Like Virus vB_EcoM_VpaE1.

Šimoliūnas E, Vilkaitytė M, Kaliniene L, Zajančkauskaitė A, Kaupinis A, Staniulis J, Valius M, Meškys R, Truncaitė L.

Viruses. 2015 Nov 27;7(12):6163-81. doi: 10.3390/v7122932.

17.

Quantitative proteomic analysis of anticancer drug RH1 resistance in liver carcinoma.

Ger M, Kaupinis A, Nemeikaite-Ceniene A, Sarlauskas J, Cicenas J, Cenas N, Valius M.

Biochim Biophys Acta. 2016 Feb;1864(2):219-32. doi: 10.1016/j.bbapap.2015.11.005. Epub 2015 Nov 17.

PMID:
26596252
18.

Human Amniotic Fluid Mesenchymal Stem Cells from Second- and Third-Trimester Amniocentesis: Differentiation Potential, Molecular Signature, and Proteome Analysis.

Savickiene J, Treigyte G, Baronaite S, Valiuliene G, Kaupinis A, Valius M, Arlauskiene A, Navakauskiene R.

Stem Cells Int. 2015;2015:319238. doi: 10.1155/2015/319238. Epub 2015 Aug 17.

19.

Suppression of a Specific Intracellular Uptake Pathway by a Saturating Accumulation of Quantum Dots.

Damalakiene L, Karabanovas V, Bagdonas S, Pupelis L, Valius M, Rotomskis R.

J Biomed Nanotechnol. 2015 May;11(5):841-53.

PMID:
26349396
20.

Roscovitine in cancer and other diseases.

Cicenas J, Kalyan K, Sorokinas A, Stankunas E, Levy J, Meskinyte I, Stankevicius V, Kaupinis A, Valius M.

Ann Transl Med. 2015 Jun;3(10):135. doi: 10.3978/j.issn.2305-5839.2015.03.61. Review.

21.

Belinostat, a potent HDACi, exerts antileukaemic effect in human acute promyelocytic leukaemia cells via chromatin remodelling.

Valiuliene G, Stirblyte I, Cicenaite D, Kaupinis A, Valius M, Navakauskiene R.

J Cell Mol Med. 2015 Jul;19(7):1742-55. doi: 10.1111/jcmm.12550. Epub 2015 Apr 11.

22.

Highlights of the Latest Advances in Research on CDK Inhibitors.

Cicenas J, Kalyan K, Sorokinas A, Jatulyte A, Valiunas D, Kaupinis A, Valius M.

Cancers (Basel). 2014 Oct 27;6(4):2224-42. doi: 10.3390/cancers6042224. Review.

23.

Isolation and characterization of vB_ArS-ArV2 - first Arthrobacter sp. infecting bacteriophage with completely sequenced genome.

Šimoliūnas E, Kaliniene L, Stasilo M, Truncaitė L, Zajančkauskaitė A, Staniulis J, Nainys J, Kaupinis A, Valius M, Meškys R.

PLoS One. 2014 Oct 21;9(10):e111230. doi: 10.1371/journal.pone.0111230. eCollection 2014.

24.

Surface properties of quantum dots define their cellular endocytic routes, mitogenic stimulation and suppression of cell migration.

Karabanovas V, Zitkus Z, Kuciauskas D, Rotomskis R, Valius M.

J Biomed Nanotechnol. 2014 May;10(5):775-86.

PMID:
24734530
25.

Klebsiella phage vB_KleM-RaK2 - a giant singleton virus of the family Myoviridae.

Simoliūnas E, Kaliniene L, Truncaitė L, Zajančkauskaitė A, Staniulis J, Kaupinis A, Ger M, Valius M, Meškys R.

PLoS One. 2013 Apr 9;8(4):e60717. doi: 10.1371/journal.pone.0060717. Print 2013. Erratum in: PLoS One. 2013;8(12). doi:10.1371/annotation/a1d15675-2942-41ba-92f4-3dad6bc6cac6.

26.

Intracellular distribution of nontargeted quantum dots after natural uptake and microinjection.

Damalakiene L, Karabanovas V, Bagdonas S, Valius M, Rotomskis R.

Int J Nanomedicine. 2013;8:555-68. doi: 10.2147/IJN.S39658. Epub 2013 Feb 4.

27.

The CDK inhibitors in cancer research and therapy.

Cicenas J, Valius M.

J Cancer Res Clin Oncol. 2011 Oct;137(10):1409-18. doi: 10.1007/s00432-011-1039-4. Epub 2011 Aug 30. Review.

PMID:
21877198
28.

Adaptor protein Nck1 interacts with p120 Ras GTPase-activating protein and regulates its activity.

Ger M, Zitkus Z, Valius M.

Cell Signal. 2011 Oct;23(10):1651-8. doi: 10.1016/j.cellsig.2011.05.019. Epub 2011 Jun 2.

PMID:
21664272
29.

The somatostatin analogue TT-232 induces apoptosis in A431 cells: sustained activation of stress-activated kinases and inhibition of signalling to extracellular signal-regulated kinases.

Vántus T, Kéri G, Krivickiene Z, Valius M, Steták A, Keppens S, Csermely P, Bauer PI, Bökönyi G, Declercq W, Vandenabeele P, Merlevede W, Vandenheede JR.

Cell Signal. 2001 Oct;13(10):717-25.

PMID:
11602182
30.

JNK/SAPK activation by platelet-derived growth factor in A431 cells requires both the phospholipase C-gamma and the phosphatidylinositol 3-kinase signaling pathways of the receptor.

Assefa Z, Valius M, Vántus T, Agostinis P, Merlevede W, Vandenheede JR.

Biochem Biophys Res Commun. 1999 Aug 11;261(3):641-5.

PMID:
10441479
31.

APS, an adaptor protein containing PH and SH2 domains, is associated with the PDGF receptor and c-Cbl and inhibits PDGF-induced mitogenesis.

Yokouchi M, Wakioka T, Sakamoto H, Yasukawa H, Ohtsuka S, Sasaki A, Ohtsubo M, Valius M, Inoue A, Komiya S, Yoshimura A.

Oncogene. 1999 Jan 21;18(3):759-67.

32.

Platelet-derived growth factor stimulates protein kinase D through the activation of phospholipase Cgamma and protein kinase C.

Van Lint J, Ni Y, Valius M, Merlevede W, Vandenheede JR.

J Biol Chem. 1998 Mar 20;273(12):7038-43.

33.
34.

PLC-gamma activation is required for PDGF-betaR-mediated mitogenesis and monocytic differentiation of myeloid progenitor cells.

Alimandi M, Heidaran MA, Gutkind JS, Zhang J, Ellmore N, Valius M, Kazlauskas A, Pierce JH, Li W.

Oncogene. 1997 Jul 31;15(5):585-93.

36.

Mitogen-activated protein kinase activation is insufficient for growth factor receptor-mediated PC12 cell differentiation.

Vaillancourt RR, Heasley LE, Zamarripa J, Storey B, Valius M, Kazlauskas A, Johnson GL.

Mol Cell Biol. 1995 Jul;15(7):3644-53.

38.
41.
42.

[Studies on cause of migratory instinct in birds].

VALIUS MI.

Dokl Akad Nauk SSSR. 1952 Dec 21;87(6):1071-4. Undetermined Language. No abstract available.

PMID:
13021030
43.

[On the occurrence of tocopherol-like substances in Tilia].

NEUGEBAUER H, KUPPERS-FIRSCHER G, VALIUS M.

Arzneimittelforschung. 1951 Nov;1(8):377. Undetermined Language. No abstract available.

PMID:
13041650

Supplemental Content

Loading ...
Support Center